Page results
-
The Central Venous Access Team provides a nurse-led service to teenagers and adults who have been referred to UCLH for cancer treatment.
-
This information explains robotic-assisted surgery for pelvic organ prolapse. Keyhole surgery using robotic assistance is used to lift up the pelvic organs.
-
We welcome your feedback about your experience of NHNN and NCC. Your comments will be used to monitor and improve the service we provide.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
-
The UCLH dermatology department diagnoses and treats all forms of skin cancer including low- and high- risk basal cell carcinomas (BCC), squamous cell carcinomas (SCC) and malignant melanoma.
-
This page is for those who have been referred for radiotherapy to the abdomen.
-
Specialist and interventional cardiology outpatient services are provided by the Barts Heart Centre. General cardiology outpatients for local patients will continue to be provided by University College Hospital.
-
La enfermedad de Chagas está causada por la infección del parásito llamado Trypanosoma cruzi.
-
OPAT (Outpatient Parenteral Antimicrobial Therapy) is a safe and convenient way to receive intravenous (IV) antibiotic therapy at home or in a clinic.
-
The UCLH play and youth services team provides therapeutic, diagnostic, developmental and specialised play interventions to help support children and young people during their time at UCLH.
File results
-
FOI/2022/0246 - Adult haematology services
-
FOI/2022/0247 - Care Axial SpA referrals to rheumatology
-
FOI/2022/0249 - Robotic process automation/ intelligent automation technology
-
FOI/2022/0263 - Rheumatology prescriptions
-
FOI/2022/0268 - Total bed management contract with Medstrom Ltd
-
FOI/2022/0269 - Allied health professionals job planning and junior doctor rotas software
-
FOI/2022/0273 - Proton therapy
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0276 - Biologic medicines within dermatology
-
FOI/2022/0280 - Applications or tools to communicate digitally with patients